Figure 1
Schema for multicenter pilot study of angiogenesis inhibitor therapy after neoadjuvant chemotherapy. BID, twice a day; IV, intravenously; PO, orally; qd, once daily.
Figure 1 | Breast Cancer Research
Schema for multicenter pilot study of angiogenesis inhibitor therapy after neoadjuvant chemotherapy. BID, twice a day; IV, intravenously; PO, orally; qd, once daily.